Considering the potential benefits of over-the-counter naloxone

KE Evoy, LG Hill, CS Davis - Integrated Pharmacy Research and …, 2021 - Taylor & Francis
Since 1999, annual opioid-related overdose (ORO) mortality has increased more than six-
fold. In response to this crisis, the US Department of Health and Human Services outlined a …

Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review

T Bommersbach, M Justen, AM Bunting… - International Journal of …, 2023 - Elsevier
Background The majority of patients with opioid use disorder do not receive medications for
opioid use disorder (MOUD), especially in rural areas. The patient-centered access to …

Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden

NJ Kazerouni, AN Irwin, XA Levander, J Geddes… - Drug and alcohol …, 2021 - Elsevier
Background Pharmacies sometimes restrict access to buprenorphine-naloxone
(buprenorphine) for individuals with opioid use disorder. The objective of this study was to …

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 US states

LG Hill, LJ Loera, SB Torrez, T Puzantian… - Drug and alcohol …, 2022 - Elsevier
Background Prompt access to prescribed buprenorphine/naloxone films (BUP/NX) and
naloxone nasal spray (NNS) is vital for patients with opioid use disorder (OUD), but multiple …

Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: a national survey of community-based pharmacists

LG Hill, AE Light, TC Green, AL Burns, PS Zadeh… - Journal of the American …, 2023 - Elsevier
Background Increasing buprenorphine prescribing for opioid use disorder (OUD) has been
a major focus of US opioid response efforts. However, concerns related to dispensing …

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription …

TC Green, J Bratberg, AN Irwin, J Boggis, M Gray… - Substance …, 2022 - Taylor & Francis
Access to the opioid antidote naloxone is a critical component of addressing the opioid
crisis. Naloxone is a population-level prevention intervention associated with substantial …

[HTML][HTML] Factors in rural community buprenorphine dispensing

EG Major, CG Wilson, DM Carpenter, JC Harless… - Exploratory Research in …, 2023 - Elsevier
Background There are pharmacy-related barriers to the dispensing of buprenorphine for the
treatment of opioid use disorders. These include pharmacists' moral objections and mistrust …

[HTML][HTML] Rural community pharmacist willingness to dispense Suboxone®-A secret shopper investigation in South-Central Appalachia

G Trull, E Major, C Harless, W Zule, B Ostrach… - Exploratory Research in …, 2021 - Elsevier
Background Buprenorphine access is limited for patients with opioid use disorder, especially
in rural areas. Telephone audits have identified pharmacist limitations to the dispensing of …

Naloxone accessibility without an outside prescription from US community pharmacies: a systematic review

RK Lai, KE Friedson, KR Reveles, K Bhakta… - Journal of the American …, 2022 - Elsevier
Background Recent evidence has identified limited naloxone accessibility in community
pharmacies. Objectives To summarize current literature regarding naloxone accessibility …

Addressing buprenorphine bottlenecks in the context of MAT Act implementation: A shared responsibility

B Ostrach, L Hill, D Carpenter, R Pollini - Journal of the American …, 2023 - Elsevier
Medications for opioid use disorder (OUD) such as buprenorphine reduce overdose
mortality and other opioid related acute health events but have historically been highly …